Registration number:
NS Medical Consultancy Limited
trading as
for the Period from 15 March 2022 to 31 March 2023
NS Medical Consultancy Limited
trading as NS Medical Limited
Contents
Company Information |
|
Abridged Balance Sheet |
|
Notes to the Abridged Financial Statements |
NS Medical Consultancy Limited
trading as NS Medical Limited
Company Information
Director |
Navina Sullivan |
Registered office |
|
Auditors |
Auditor details
|
NS Medical Consultancy Limited
trading as NS Medical Limited
(Registration number: 13977579)
Abridged Balance Sheet as at 31 March 2023
Note |
2023 |
|
Current assets |
||
Debtors |
|
|
Cash at bank and in hand |
|
|
|
||
Creditors: Amounts falling due within one year |
( |
|
Net assets |
|
|
Capital and reserves |
||
Called up share capital |
50 |
|
Retained earnings |
45,733 |
|
Shareholders' funds |
45,783 |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
......................................... |
NS Medical Consultancy Limited
trading as NS Medical Limited
Notes to the Abridged Financial Statements for the Period from 15 March 2022 to 31 March 2023
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
Going concern
NS Medical Consultancy Limited
trading as NS Medical Limited
Notes to the Abridged Financial Statements for the Period from 15 March 2022 to 31 March 2023
Audit report
.........................................
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
NS Medical Consultancy Limited
trading as NS Medical Limited
Notes to the Abridged Financial Statements for the Period from 15 March 2022 to 31 March 2023
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
Debtors |
Debtors includes £Nil due after more than one year.
Share capital |
Allotted, called up and fully paid shares
2023 |
||
No. |
£ |
|
|
|
50 |